Literatura académica sobre el tema "Fatigue Motor neurons"

α-Motor neurons receive synaptic inputs from spinal and supraspinal centers that comprise components either common to the motor neuron pool or independent. The input shared by motor neurons—common input—determines force control. The aim of the study was to investigate the changes in the strength of common synaptic input delivered to motor neurons with changes in force and with fatigue, two conditions that underlie an increase in the net excitatory drive to the motor neurons. High-density surface electromyogram (EMG) signals were recorded from the tibialis anterior muscle during contractions at 20, 50, and 75% of the maximal voluntary contraction force (in 3 sessions separated by at least 2 days), all sustained until task failure. EMG signal decomposition identified the activity of a total of 1,245 motor units. The coherence values between cumulative motor unit spike trains increased with increasing force, especially for low frequencies. This increase in coherence was not observed when comparing two subsets of motor units having different recruitment thresholds, but detected at the same force level. Moreover, the coherence values for frequencies <5 Hz increased at task failure with respect to the beginning of the contractions for all force levels. In conclusion, the results indicated that the relative strength of common synaptic input to motor neurons increases with respect to independent input when the net excitatory drive to motor neurons increases as a consequence of a change in force and fatigue.

Motor neuron disease is a neurodegenerative disease characterized by loss of upper motor neuron in the motor cortex and lower motor neurons in the brain stem and spinal cord. Death occurs 2–4 years after the onset of the disease. A complex interplay of cellular processes such as mitochondrial dysfunction, oxidative stress, excitotoxicity, and impaired axonal transport are proposed pathogenetic processes underlying neuronal cell loss. Currently evidence exists for the use of riluzole as a disease modifying drug; multidisciplinary team care approach to patient management; noninvasive ventilation for respiratory management; botulinum toxin B for sialorrhoea treatment; palliative care throughout the course of the disease; and Modafinil use for fatigue treatment. Further research is needed in management of dysphagia, bronchial secretion, pseudobulbar affect, spasticity, cramps, insomnia, cognitive impairment, and communication in motor neuron disease.

Large-diameter myelinated phrenic afferents discharge in phase with diaphragm contraction, and smaller diameter fibers discharge across the respiratory cycle. In this article, we review the phrenic afferent literature and highlight areas in need of further study. We conclude that 1) activation of both myelinated and nonmyelinated phrenic sensory afferents can influence respiratory motor output on a breath-by-breath basis; 2) the relative impact of phrenic afferents substantially increases with diaphragm work and fatigue; 3) activation of phrenic afferents has a powerful impact on sympathetic motor outflow, and 4) phrenic afferents contribute to diaphragm somatosensation and the conscious perception of breathing. Much remains to be learned regarding the spinal and supraspinal distribution and synaptic contacts of myelinated and nonmyelinated phrenic afferents. Similarly, very little is known regarding the potential role of phrenic afferent neurons in triggering or modulating expression of respiratory neuroplasticity.

SMA (Spinal muscular atrophies) are category of hereditary inflammation in the funiculars and lower brain stem, tissue fatigue, and degeneration characterized by motor neuron failure. The analytic and genetic phenotypes incorporate a diverse continuum distinguished depending on age of onset, tissue participation arrangement, and inheritance arrangement. Rapid advancements in genetic science have expedite the discovery of causative genes over the past few years, and provide significant access in awareness the biochemical and neurological basis of Spinal muscular atrophies and insights into the motor neurons' selective deficiency. Popular path physiological topics include Ribonucleic Acid metabolism and splicing abnormalities, axonal transmission, and motor neurons' advancement and communication. These also collectively revealed possible innovative prevention methods and comprehensive attempts are what benefits does the company offer? Although a range of promising therapeutic therapies for Spinal muscular atrophies is emerging, it is essential to identify therapeutic windows and establish responsive and appropriate biomarkers to promote future analytic trial success. This research offers a description of Spinal muscular atrophies' logical manifestations and genetics. It discusses recent advancements in learning—mechanisms for the pathogenesis of inflammation and new treatment methods.

1. Crayfish phasic motor synapses produce large initial excitatory postsynaptic potentials (EPSPs) that fatigue rapidly during high-frequency stimulation. Periodic in vivo stimulation of an identified phasic abdominal extensor motor neuron (axon 3) induced long-term adaptation (LTA) of neuromuscular transmission: initial EPSP amplitude became smaller and synaptic depression was significantly reduced. We tested the hypothesis that activity-induced synaptic fatigue-resistance seen during LTA was dependent upon, or correlated with, mitochondrial oxidative competence. 2. Periodic unilateral conditioning stimulation of axon 3 entering each of two adjacent homologous abdominal segments (segments 2 and 3) increased the synaptic stamina in both "conditioned" axons; mean final EPSP amplitudes, recorded after 20 min of 5-Hz test stimulation, were significantly larger than those measured with the same protocol from contralateral unstimulated axons. 3. During 5-Hz test stimulation of the conditioned axon 3 of segment 3, acute superfusion with 0.8 mM dinitrophenol or 20 mM sodium azide [inhibitors of oxidative adenosinetriphosphate (ATP) synthesis] produced increased synaptic depression. Drug-free saline superfusion of the conditioned axon 3 of segment 2 in these same animals did not affect the increased synaptic fatigue resistance seen in this segment. Thus both successful induction (in axon 3 of saline-perfused segment 2) and attenuation (in axon 3 of drug-perfused segment 3) of the increased synaptic stamina can be demonstrated with this twin-segment conditioning protocol. 4. Confocal microscopic imaging of mitochondrial rhodamine-123 (Rh123) fluorescence was used to assess relative oxidative competence of conditioned and unconditioned phasic axons. Conditioned phasic axons showed significantly higher mean mitochondrial Rh123 fluorescence than contralateral unstimulated axons. In the same preparations that showed increased postconditioning Rh123 fluorescence, the synaptic fatigue resistance measured from conditioned axon 3 was also significantly greater than that recorded from contralateral unstimulated axon 3. 5. Axotomy of the phasic extensor nerve root (containing axon 3), before in vivo conditioning stimulation of its decentralized segment, prevented induction of both the increased synaptic stamina in axon 3 and the enhanced mitochondrial fluorescence in decentralized motor axons of the nerve root. Hence, induction of both changes requires axonal transport of materials between the soma and the motor synapses of axon 3. 5. Axotomy of the phasic extensor nerve root (containing axon 3), before in vivo conditioning stimulation of its decentralized segment, Prevented induction of both the increased synaptic stamina in axon 3 and the enhanced mitochondrial fluorescence in decentralized motor axons of the nerve root Hence, induction of both changes requires axonal transport of materials between the soma and the motor synapses of axon 3 6. Because mitochondrial Rh123 fluorescence is primarily dependent upon the oxidative activity of these organelles, our findings suggest that conditioning stimulation of phasic extensor axon 3 increases its mitochondrial oxidative competence and that the enhanced synaptic stamina seen during LTA in axon 3 is correlated with, and dependent upon, oxidative activity.(ABSTRACT TRUNCATED AT 400 WORDS)

Introduction Neuromuscular fatigue refers to a reduction in maximal force generation capacity, and is categorized as central and peripheral. Central fatigue is defined as a reduction in the ability of the central nervous system to voluntarily activate muscles, and peripheral fatigue indicates a decrease in the contractile strength of muscle fibers. During high intensity exercise, motor neurons are involved in the recruitment of type IIB muscle fibers as they are fast-twitch, high glycolytic, and have low aerobic capacity. Furthermore, group III and IV muscle afferents detect the physiological circumstances in the body and convey signals to the brain that influence the onset of central and peripheral fatigue. Methods A PRISMA flow diagram was created to record relevant studies found from scholarly databases. Inclusion criteria required studies from 2005 to 2017, and subject grouping headings required key terms indicating that the presence of central and peripheral fatigue was analyzed on healthy adult subjects performing exercise. To ensure that high quality studies were analyzed, each article was independently rated using the National Institute of Health Quality Assessment Tool criteria. Discussion During low intensity exercise, asynchronous motor unit recruitment is involved in delaying the onset of muscle fatigue. However, this is not apparent in high intensity exercises, as maximal motor unit firing is required in order to sustain a maximal level of force output. Persistent firing of action potentials to maintain muscle contraction results in acetylcholine depletion at the motor end plate, initiating the process of central fatigue. Furthermore, due to prolonged metabolite accumulation in skeletal muscle fibers, group III and IV afferents convey signals to the motor cortex and cause a reduction in the action potential conduction velocities along the contracting muscle. This leads to the onset of peripheral fatigue. As high intensity exercise proceeds, electromyogram (EMG) measurements display this as an increase in amplitude to reflect heightened motor unit recruitment and a compressed power density spectrum alongside a decreased centre frequency. This is determined by the innervated muscle fiber’s conduction velocity and subsequent variations in the action potential waveform shape. Conclusion A record of current studies systematically display the overview of muscle fatigue and its underlying mechanisms during exercise. However, further research is yet to be conducted for a more comprehensive understanding regarding the onset and recovery of neuromuscular fatigue in varied population demographics and physiological circumstances. Likewise, the distinctive roles of group III and IV muscle afferents in supraspinal stimulation require further investigation in order to gain a holistic understanding of their involvement in central fatigue and resistance training. Additional research in this subject matter is currently being explored through technology involving imaging studies, as they have potential to elucidate motor cortex activity alongside other regions of the brain and portray neuromuscular muscle fatigue eminently.

Nguyen, Peter V., Leo Marin, and Harold L. Atwood. Synaptic physiology and mitochondrial function in crayfish tonic and phasic motor neurons. J. Neurophysiol. 78: 281–294, 1997. Phasic and tonic motor neurons of crustaceans differ strikingly in their junctional synaptic physiology. Tonic neurons generally produce small excitatory postsynaptic potentials (EPSPs) that facilitate strongly as stimulation frequency is increased, and normally show no synaptic depression. In contrast, phasic neurons produce relatively large EPSPs with weak frequency facilitation and pronounced depression. We addressed the hypothesis that mitochondrial function is an important determinant of the features of synaptic transmission in these neurons. Mitochondrial fluorescence was measured with confocal microscopy in phasic and tonic axons and terminals of abdominal and leg muscles after exposure to supravital mitochondrial fluorochromes, rhodamine-123 (Rh123) and 4-diethylaminostyryl-N-methylpyridinium iodide (4-Di-2-Asp). Mitochondria of tonic axons and neuromuscular junctions had significantly higher mean Rh123 and 4-Di-2-Asp fluorescence than in phasic neurons, indicating more accumulation of the fluorochromes. Mitochondrial membrane potential, which is responsible for Rh123 uptake and is related to mitochondrial oxidative activity (the production of ATP by oxidation of metabolic substrates), is likely higher in tonic axons. Electron microscopy showed that tonic axons contain approximately fivefold more mitochondria per μm2 cross-sectional area than phasic axons. Neuromuscular junctions of tonic axons also have a much higher mitochondrial content than those of phasic axons. We tested the hypothesis that synaptic fatigue resistance is dependent on mitochondrial function in crayfish motor axons. Impairment of mitochondrial function by uncouplers of oxidative phosphorylation, dinitrophenol or carbonyl cyanide m-chlorophenylhydrazone, or by the electron transport inhibitor sodium azide, led to marked synaptic depression of a tonic axon and accelerated depression of a phasic axon during maintained stimulation. Iodoacetate, an inhibitor of glycolysis, and chloramphenicol, a mitochondrial protein synthesis inhibitor, had no significant effects on either mitochondrial fluorescence or synaptic depression in tonic or phasic axons. Collectively, the results provide evidence that mitochondrial oxidative metabolism is important for sustaining synaptic transmission during maintained stimulation of tonic and phasic motor neurons. Tonic neurons have a higher mitochondrial content and greater oxidative activity; these features are correlated with their greater resistance to synaptic depression. Conversely, phasic neurons have a lower mitochondrial content, less oxidative activity, and greater synaptic fatigability.

Cutaneous coupling with lower limb motor neurons has long been known. We set out to establish whether this pathway could serve a purpose other than muscular modulation during standing and walking. We found that during a submaximal contraction of the plantar flexor muscles, the addition of intermittent cutaneous stimulation to the skin of the foot sole resulted in an increase in time to task failure by 15%, which was over a minute longer in duration. We conclude that skin stimulation may serve as a mechanism to mitigate fatigue.

In paraplegic patients with upper motor neuron lesions the signal path from the central nervous system to the muscles is interrupted. Functional electrical stimulation applied to the lower motor neurons can replace the lacking signals. A so–called neuroprosthesis may be used to restore motor function in paraplegic patients on the basis of functional electrical stimulation. However, the control of multiple joints is difficult due to the complexity, nonlinearity, and time–variance of the system involved. Furthermore, effects such as muscle fatigue, spasticity, and limited force in the stimulated muscle further complicate the control task. Mathematical models of the human musculoskeletal system can support the development of neuroprostheses. In this article a detailed overview of the existing work in the literature is given and two examples developed by the author are presented that give an insight into model–based development of neuroprostheses for paraplegic patients. It is shown that modelling the musculoskeletal system can provide better understanding of muscular force production and movement coordination principles. Models can also be used to design and test stimulation patterns and feedback control strategies. Additionally, model components can be implemented in a controller to improve control performance. Eventually, the use of musculoskeletal models for neuroprosthesis design may help to avoid internal disturbances such as fatigue and optimize muscular force output. Furthermore, better controller quality can be obtained than in previous empirical approaches. In addition, the number of experimental tests to be performed with human subjects can be reduced. It is concluded that mathematical models play an increasing role in the development of reliable closed–loop controlled, lower extremity neuroprostheses.

In aging Fischer 344 rats, phrenic motor neuron loss, neuromuscular junction abnormalities, and diaphragm muscle (DIAm) sarcopenia are present by 24 mo of age, with larger fast-twitch fatigue-intermediate (type FInt) and fast-twitch fatigable (type FF) motor units particularly vulnerable. We hypothesize that in old rats, DIAm neuromuscular transmission deficits are specific to type FInt and/or FF units. In phrenic nerve/DIAm preparations from rats at 6 and 24 mo of age, the phrenic nerve was supramaximally stimulated at 10, 40, or 75 Hz. Every 15 s, the DIAm was directly stimulated, and the difference in forces evoked by nerve and muscle stimulation was used to estimate neuromuscular transmission failure. Neuromuscular transmission failure in the DIAm was observed at each stimulation frequency. In the initial stimulus trains, the forces evoked by phrenic nerve stimulation at 40 and 75 Hz were significantly less than those evoked by direct muscle stimulation, and this difference was markedly greater in 24-mo-old rats. During repetitive nerve stimulation, neuromuscular transmission failure at 40 and 75 Hz worsened to a greater extent in 24-mo-old rats compared with younger animals. Because type IIx and/or IIb DIAm fibers (type FInt and/or FF motor units) display greater susceptibility to neuromuscular transmission failure at higher frequencies of stimulation, these data suggest that the age-related loss of larger phrenic motor neurons impacts nerve conduction to muscle at higher frequencies and may contribute to DIAm sarcopenia in old rats. NEW & NOTEWORTHY Diaphragm muscle (DIAm) sarcopenia, phrenic motor neuron loss, and perturbations of neuromuscular junctions (NMJs) are well described in aged rodents and selectively affect FInt and FF motor units. Less attention has been paid to the motor unit-specific aspects of nerve-muscle conduction. In old rats, increased neuromuscular transmission failure occurred at stimulation frequencies where FInt and FF motor units exhibit conduction failures, along with decreased apposition of pre- and postsynaptic domains of DIAm NMJs of these units.

All motor behaviours are expressed via the activation of alpha motoneurones, the final common path of the central nervous system. The corticospinal tract conveys neural information from the motor cortex to motoneurones. This thesis focuses on the corticospinal control of human motoneurones during voluntary contraction and fatigue. First, output of motoneurones to corticospinal inputs is described for a wide range of contraction strengths. Results show that motoneurones become less responsive during strong contractions whereas motor cortical output cells are not limited in the same way. Comparison of motoneurone output to different strength corticospinal inputs and of different motoneurone pools demonstrates an important role for motor unit firing rates in determining the excitability of motoneurones during strong contractions. Next, the reflex actions of group III and IV muscle afferents on motoneurones are investigated. These studies address a long and ongoing debate about the role of these afferents to the slowing of motor unit firing rates during sustained contractions. It was believed that these afferents inhibit motoneurones and contribute to fatigue. However, findings demonstrate that human motoneurones innervating extensor and flexor muscles are not uniformly affected by fatigue-sensitive afferents. Thus afferent inputs from homonymous and antagonist muscles depress extensor motoneurones but facilitate flexor motoneurones. When group III and IV muscle afferents are activated by hypertonic saline, motoneurones of both extensors and flexors are facilitated. This demonstrates parallel excitatory and inhibitory pathways from group III and IV muscle afferents to extensor motoneurones, which are activated under different conditions. Furthermore, the excitation is more pronounced for high-threshold motoneurones. In addition to the effects mediated at motoneurones, activity in group III and IV afferents inhibits motor cortical cells. The final studies investigate changes in the cervical propriospinal pathway with fatigue. This pathway transmits part of the voluntary drive to motoneurones, in parallel with the direct corticospinal pathway. The studies demonstrate that during fatigue, there are coordinated changes in the excitation mediated via this pathway to motoneurones of both fatigued and non-fatigued muscles of the upper limb. In summary, this thesis demonstrates novel aspects of the corticospinal control of motoneurones during voluntary contraction and fatigue.

Esclerose lateral amiotrófica (ELA) é uma doença neurológica progressiva e fatal, caracterizada por perda dos neurônios motores, levando à fraqueza muscular global. As funções sensitivas e mentais são preservadas durante todo o curso da doença. A esclerose lateral amiotrófica tem uma prevalência de 6 por 100.000 pessoas e o início da doença é geralmente entre os 40 a 60 anos de idade. O prognóstico é reservado e em média os pacientes vivem de 3 a 5 anos após o diagnóstico médico. Com a progressão da doença outros sintomas surgem como fraqueza dos membros, comprometimento da fala, aumento da salivação, dificuldades de deglutição, dificuldades para deambular e fadiga muscular. As alterações dos músculos respiratórios levam à falência respiratória, que é a maior causa de óbito nos pacientes com esclerose lateral amiotrófica. Fadiga é definida como a queda da máxima contração isométrica voluntária e falta de tolerância do músculo sob esforço. A máxima contração isométrica voluntária depende de uma cadeia de eventos que se inicia no córtex motor - condutor excitatório dos neurônios motores superior e inferior, e se continua na transmissão pela junção neuromuscular, no acoplamento excitação-contração e na contração da fibra muscular que depende de um suprimento energético metabólico. A fadiga muscular ocorre em pacientes com esclerose lateral amiotrófica prejudicando a função e a qualidade de vida dos pacientes. O objetivo deste trabalho foi: 1) Quantificar a freqüência da fadiga na esclerose lateral amiotrófica; 2) Analisar a evolução da fadiga nos pacientes; 3) Correlacionar a presença da fadiga com fatores como a funcionalidade, a qualidade de vida, a depressão, a dispnéia, e a sonolência, idade e duração da doença em meses. O grupo controle compôs-se de 60 indivíduos (familiares de funcionários do hospital e da equipe multidisciplinar) que não apresentavam história de doenças pregressas. O grupo teste constitui-se de 60 pacientes com diagnóstico de esclerose lateral amiotrófica. O diagnóstico foi realizado por dois neurologistas independentes e baseou-se na presença de história clínica, exame neurológico e estudos neurofisiológicos compatíveis com esclerose lateral amiotrófica, segundo os critérios de El Escorial da Federação Mundial de Neurologia; além disso, houve a investigação complementar por meio de testes hematológicos, bioquímicos, sorológicos, genéticos e radiológicos para excluir outras patologias. Os pacientes dos grupos controle e teste foram entrevistados pela pesquisadora para aplicação de questionários com escalas para verificação da presença de funcionalidade, de qualidade de vida, de depressão, de dispnéia, de sonolência e de fadiga; e os pacientes do grupo teste foram submetidos à avaliação fisioterapêutica no início do estudo e a cada 3 meses, totalizando 12 meses de coletas. O grupo teste apresentou fadiga significantemente maior em relação ao grupo controle, bem como alterações nos questionários de funcionalidade, de qualidade de vida, de depressão, de dispnéia e de sonolência. Percebeu-se que a fadiga foi evolutiva durante os meses de acompanhamento da pesquisa. A fadiga correlacionou-se com a idade, mostrando que os pacientes mais jovens apresentaram maior grau de fadiga que os pacientes mais idosos. Os resultados desta pesquisa sugerem que a fadiga é um dos problemas que afetam os pacientes com ELA; o fato de não ter correlação com outros problemas estudados sugere que a fadiga deve merecer pesquisa e tratamento individualizados no paciente com ELA, principalmente pelo fato de que os resultados sugeriram piora da fadiga no decorrer da evolução da ELA
Amyotrophic lateral sclerosis (ALS) is a progressive and fatal neurological disease, characterized by loss of the motor neurons, taking to the global muscular weakness. The sensitive and mental functions are preserved during whole the course of the disease. The ALS has a prevalence of 6 for 100.000 people and the beginning of the disease is usually among the 40 to 60 years of age. The prognostic is reserved and on average the patients live from 3 to 5 years after the medical diagnosis. With the progression of the disease other symptoms they appear as weakness of the members, compromising of the speech, increase of the salivation, deglutition difficulties, difficulties to stroll and it fatigues muscular. The alterations of the breathing muscles take to the breathing bankruptcy, that is the largest death cause in the patients with ALS. Fatigue is defined as the fall of the maxim voluntary isometric contraction and lack of tolerance of the muscle under effort. The maxim voluntary isometric contraction depends on a chain of events that begins in the motor cortex - driver excitatory of the neurons motor superior and inferior, and it is continued in the transmission by the junction neuromuscular, in the joining excitement-contraction and in the contraction of the muscular fiber that depends on a metabolic energy supply. The muscular fatigue happens in patients with ALS harming the function and the quality of the patients\' life. The objective of this work was: 1) to quantify the frequency of the fatigue in the ALS; 2) to analyze the evolution of the fatigue in the patients; 3) to correlate the presence of the fatigue with factors as the functionality, the life quality, the depression, the dispnéa, and the sleepiness, age and duration of the disease in months. The group control was composed of 60 individuals (family of employees of the hospital and of the team multidisciplinar) that didn\'t present history of past diseases. The group test is constituted of 60 patients with diagnosis of ALS. The diagnosis was accomplished by two independent neurologists and he/she based on the presence of clinical history, neurological exam and studies compatible neurophisiologycs with ALS, according to the criteria of El Escorial of the World Federation of Neurology; besides, there was the complement investigation through tests and exams to exclude other pathologies. The patients of the groups control and test were interviewed by the researcher for application of questionnaires with scales for verification of the functionality presence, of life quality, of depression, of dispnéa, of sleepiness and of fatigue; and the patients of the group test they were submitted to the evaluation physiotherapy in the beginning of the study and every 3 months, totaling 12 months of collections. The group test presented fatigue larger significantly in relation to the group it controls, as well as alterations in the functionality questionnaires, of life quality, of depression, of dispnéa and of sleepiness. It was noticed that the fatigue was evolutionary during the months of accompaniment of the research. The fatigue was correlated with the age, showing that the youngest patients presented larger degree of fatigue than the most senior patients. The results of this research suggest that the fatigue is one of the problems that affect the patients with ALS; the fact of not having correlation with other studied problems suggests that the fatigue should deserve research and treatment individualized in the patient with ALS, mainly for the fact that the results suggested worsening of the fatigue in elapsing of the evolution of the ALS

Thesis (M.Sc.)--York University, 2004. Graduate Programme in Kinesiology and Health Science.
Typescript. Includes bibliographical references. Also available on the Internet. MODE OF ACCESS via web browser by entering the following URL:http://gateway.proquest.com/openurl?url%5Fver=Z39.88-2004&res%5Fdat=xri:pqdiss&rft%5Fval%5Ffmt=info:ofi/fmt:kev:mtx:dissertation&rft%5Fdat=xri:pqdiss:MQ99279

Weakness is a common complaint. Most patients use the term weakness to imply fatigue, general illness, or myalgias. Determining whether a patient has actual neuromuscular weakness can be a diagnostic challenge. Disease of the motor system can occur at all levels of the nervous system. This chapter considers disorders of the lower motor neuron, including disorders of muscle (myopathies), the neuromuscular junction, and motor nerves.